On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpoints
From MaRDI portal
Publication:4224607
DOI10.1080/10543409808835238zbMath0914.62103OpenAlexW2059527467WikidataQ52242998 ScholiaQ52242998MaRDI QIDQ4224607
Publication date: 27 June 1999
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/10543409808835238
Related Items (7)
Notes on odds ratio estimation for a randomized clinical trial with noncompliance and missing outcomes ⋮ Interval estimation of odds ratio in a stratified randomized clinical trial with noncompliance ⋮ Novel Bayesian methods for non-inferiority tests based on relative risk and odds ratio for dichotomous data ⋮ Notes on Interval Estimation of Odds Ratio in Matched Pairs under Stratified Sampling ⋮ CLINICAL EQUIVALENCE ⋮ IDENTIFYING THE MAXIMUM SAFE DOSE: A MULTIPLE TESTING APPROACH ⋮ Notes on Test Homogeneity of the Odds Ratio in Matched Pairs Under Stratified Sampling: A Monte Carlo Evaluation
Cites Work
- Unnamed Item
- THE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIES
- On estimating binomial response relations
- On the Combination of Relative Risks
- Determining equivalence and the impact of sample size in anti-infective studies: a point to consider
- Probabilities and sample sizes for the two one-sided tests procedure
- Two one-sided tests procedures in establishing therapeutic equivalence with binary clinical endpoints: fixed sample performances and sample size derformination
- Accurate Confidence Intervals for the Ratio of Specific Occurrence/Exposure Rates in Risk and Survival Analysis
This page was built for publication: On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpoints
